Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Pharma
Pfizer details survival win in bid for broad prostate cancer nod
Pfizer hopes a unique life-extension benefit for Talzenna can serve to further expand the drug's already broadest-in-class prostate cancer label.
Angus Liu
Feb 13, 2025 10:00am
AZ's Truqap carves path in prostate cancer with phase 3 win
Nov 25, 2024 11:12am
Novartis complies with FDA 'flexibility' ask in Pluvicto filing
Oct 29, 2024 10:51am
After buyouts, Telix unveils new radiopharma spinoff Rhine
Oct 22, 2024 3:05pm
Boston Sci creates docuseries to destigmatize male incontinence
Oct 16, 2024 7:35am
Pfizer targets broad Talzenna label in prostate cancer
Oct 10, 2024 10:18am